Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model

Maurizio Viale, Marta Rossi, Eleonora Russo, Michele Cilli, Anna Aprile, Aldo Profumo, Pierluigi Santi, Carla Fenoglio, Sergio Cafaggi, Mattia Rocco

Research output: Contribution to journalArticle

Abstract

Fibrin gels are attractive biomaterials for local delivery of a variety of agents, from drugs to proteins. Similarly, polymer-anticancer-drug conjugates and nanoparticles are emerging as potential candidates for cancer treatment. Combining these different approaches, we have studied the efficacy of fibrin gels loaded with cisplatin (DDP) and a complex of DDP with hyaluronate (DDP-HA) for tumor growth inhibition in a melanoma model. Loaded gels prepared at relatively high fibrinogen concentration (22 mg/ml) showed good in vitro antiproliferative activities, prolonged release of the anticancer drug, and a long persistence (10-15 days) in vivo when implanted subcutaneously (sc) in immunodeficient mice. Gels loaded with DDP or DDP-HA containing 1/3 or even 1/6 of their systemic dose (6 mg/kg) and positioned under the tumor mass in mice bearing a sc human SK-Mel-28 tumor showed an antitumor activity better than that of the original parent compound given intraperitoneally (ip). Moreover, in an additional experiment in vivo, fibrin gels loaded with N-trimethyl chitosan-based nanoparticles containing a DDP-HA complex were assayed, resulting in a further 8 % improvement of anticancer activity, with lesser adverse systemic toxic effects. Taken together, these results suggest that the combination of fibrin gels and drugs complexed with suitable macromolecules holds great promise for loco-regional anticancer therapy of melanoma and other surgically removable cancer types.

Original languageEnglish
Pages (from-to)1151-1161
Number of pages11
JournalInvestigational New Drugs
Volume33
Issue number6
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Fibrin
Cisplatin
Melanoma
Gels
Neoplasms
Nanoparticles
Pharmaceutical Preparations
Poisons
Biocompatible Materials
Fibrinogen
Polymers
Growth
Proteins

Keywords

  • Cisplatin
  • Cisplatin-hyaluronate complex
  • Fibrin gel
  • Local treatment
  • Melanoma
  • Nanoparticles

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Oncology

Cite this

Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model. / Viale, Maurizio; Rossi, Marta; Russo, Eleonora; Cilli, Michele; Aprile, Anna; Profumo, Aldo; Santi, Pierluigi; Fenoglio, Carla; Cafaggi, Sergio; Rocco, Mattia.

In: Investigational New Drugs, Vol. 33, No. 6, 01.12.2015, p. 1151-1161.

Research output: Contribution to journalArticle

Viale, Maurizio ; Rossi, Marta ; Russo, Eleonora ; Cilli, Michele ; Aprile, Anna ; Profumo, Aldo ; Santi, Pierluigi ; Fenoglio, Carla ; Cafaggi, Sergio ; Rocco, Mattia. / Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model. In: Investigational New Drugs. 2015 ; Vol. 33, No. 6. pp. 1151-1161.
@article{cf984704ed4d4291bc1a4254ffba2442,
title = "Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model",
abstract = "Fibrin gels are attractive biomaterials for local delivery of a variety of agents, from drugs to proteins. Similarly, polymer-anticancer-drug conjugates and nanoparticles are emerging as potential candidates for cancer treatment. Combining these different approaches, we have studied the efficacy of fibrin gels loaded with cisplatin (DDP) and a complex of DDP with hyaluronate (DDP-HA) for tumor growth inhibition in a melanoma model. Loaded gels prepared at relatively high fibrinogen concentration (22 mg/ml) showed good in vitro antiproliferative activities, prolonged release of the anticancer drug, and a long persistence (10-15 days) in vivo when implanted subcutaneously (sc) in immunodeficient mice. Gels loaded with DDP or DDP-HA containing 1/3 or even 1/6 of their systemic dose (6 mg/kg) and positioned under the tumor mass in mice bearing a sc human SK-Mel-28 tumor showed an antitumor activity better than that of the original parent compound given intraperitoneally (ip). Moreover, in an additional experiment in vivo, fibrin gels loaded with N-trimethyl chitosan-based nanoparticles containing a DDP-HA complex were assayed, resulting in a further 8 {\%} improvement of anticancer activity, with lesser adverse systemic toxic effects. Taken together, these results suggest that the combination of fibrin gels and drugs complexed with suitable macromolecules holds great promise for loco-regional anticancer therapy of melanoma and other surgically removable cancer types.",
keywords = "Cisplatin, Cisplatin-hyaluronate complex, Fibrin gel, Local treatment, Melanoma, Nanoparticles",
author = "Maurizio Viale and Marta Rossi and Eleonora Russo and Michele Cilli and Anna Aprile and Aldo Profumo and Pierluigi Santi and Carla Fenoglio and Sergio Cafaggi and Mattia Rocco",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s10637-015-0291-x",
language = "English",
volume = "33",
pages = "1151--1161",
journal = "Investigational New Drugs",
issn = "0167-6997",
publisher = "Kluwer Academic Publishers",
number = "6",

}

TY - JOUR

T1 - Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model

AU - Viale, Maurizio

AU - Rossi, Marta

AU - Russo, Eleonora

AU - Cilli, Michele

AU - Aprile, Anna

AU - Profumo, Aldo

AU - Santi, Pierluigi

AU - Fenoglio, Carla

AU - Cafaggi, Sergio

AU - Rocco, Mattia

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Fibrin gels are attractive biomaterials for local delivery of a variety of agents, from drugs to proteins. Similarly, polymer-anticancer-drug conjugates and nanoparticles are emerging as potential candidates for cancer treatment. Combining these different approaches, we have studied the efficacy of fibrin gels loaded with cisplatin (DDP) and a complex of DDP with hyaluronate (DDP-HA) for tumor growth inhibition in a melanoma model. Loaded gels prepared at relatively high fibrinogen concentration (22 mg/ml) showed good in vitro antiproliferative activities, prolonged release of the anticancer drug, and a long persistence (10-15 days) in vivo when implanted subcutaneously (sc) in immunodeficient mice. Gels loaded with DDP or DDP-HA containing 1/3 or even 1/6 of their systemic dose (6 mg/kg) and positioned under the tumor mass in mice bearing a sc human SK-Mel-28 tumor showed an antitumor activity better than that of the original parent compound given intraperitoneally (ip). Moreover, in an additional experiment in vivo, fibrin gels loaded with N-trimethyl chitosan-based nanoparticles containing a DDP-HA complex were assayed, resulting in a further 8 % improvement of anticancer activity, with lesser adverse systemic toxic effects. Taken together, these results suggest that the combination of fibrin gels and drugs complexed with suitable macromolecules holds great promise for loco-regional anticancer therapy of melanoma and other surgically removable cancer types.

AB - Fibrin gels are attractive biomaterials for local delivery of a variety of agents, from drugs to proteins. Similarly, polymer-anticancer-drug conjugates and nanoparticles are emerging as potential candidates for cancer treatment. Combining these different approaches, we have studied the efficacy of fibrin gels loaded with cisplatin (DDP) and a complex of DDP with hyaluronate (DDP-HA) for tumor growth inhibition in a melanoma model. Loaded gels prepared at relatively high fibrinogen concentration (22 mg/ml) showed good in vitro antiproliferative activities, prolonged release of the anticancer drug, and a long persistence (10-15 days) in vivo when implanted subcutaneously (sc) in immunodeficient mice. Gels loaded with DDP or DDP-HA containing 1/3 or even 1/6 of their systemic dose (6 mg/kg) and positioned under the tumor mass in mice bearing a sc human SK-Mel-28 tumor showed an antitumor activity better than that of the original parent compound given intraperitoneally (ip). Moreover, in an additional experiment in vivo, fibrin gels loaded with N-trimethyl chitosan-based nanoparticles containing a DDP-HA complex were assayed, resulting in a further 8 % improvement of anticancer activity, with lesser adverse systemic toxic effects. Taken together, these results suggest that the combination of fibrin gels and drugs complexed with suitable macromolecules holds great promise for loco-regional anticancer therapy of melanoma and other surgically removable cancer types.

KW - Cisplatin

KW - Cisplatin-hyaluronate complex

KW - Fibrin gel

KW - Local treatment

KW - Melanoma

KW - Nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=84947443487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947443487&partnerID=8YFLogxK

U2 - 10.1007/s10637-015-0291-x

DO - 10.1007/s10637-015-0291-x

M3 - Article

C2 - 26445859

AN - SCOPUS:84947443487

VL - 33

SP - 1151

EP - 1161

JO - Investigational New Drugs

JF - Investigational New Drugs

SN - 0167-6997

IS - 6

ER -